Picture of Arcadia Biosciences logo

RKDA Arcadia Biosciences Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapValue Trap

Annual cashflow statement for Arcadia Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6.03-16.1-15.6-14-7.04
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items-12.4-6.521.041.91-1.26
Unusual Items
Other Non-Cash Items
Changes in Working Capital-12.4-4.260.118-3.51-1.45
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-30.2-25.9-14-15.3-9.63
Capital Expenditures-2.33-1.01-0.072-0.005-0.016
Purchase of Fixed Assets
Other Investing Cash Flow Items19.617.61.49-4.347.36
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities17.316.61.42-4.347.34
Financing Cash Flow Items0.063-1.16-0.488-0.497
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities20.621.94.525.510.009
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash7.6312.6-8.04-14.1-2.28